These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17460130)

  • 21. A systematic review to evaluate the accuracy of electronic adverse drug event detection.
    Forster AJ; Jennings A; Chow C; Leeder C; van Walraven C
    J Am Med Inform Assoc; 2012; 19(1):31-8. PubMed ID: 22155974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.
    Roulet L; Asseray N; Dary M; Chiffoleau A; Potel G; Ballereau F
    Int J Clin Pharm; 2012 Dec; 34(6):902-10. PubMed ID: 22923368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.
    Koutkias VG; McNair P; Kilintzis V; Skovhus Andersen K; Niès J; Sarfati JC; Ammenwerth E; Chazard E; Jensen S; Beuscart R; Maglaveras N
    Methods Inf Med; 2014; 53(6):482-92. PubMed ID: 25377477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A data-driven method to detect adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    J Biomed Inform; 2018 Sep; 85():10-20. PubMed ID: 30016721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using computerized data to identify adverse drug events in outpatients.
    Honigman B; Lee J; Rothschild J; Light P; Pulling RM; Yu T; Bates DW
    J Am Med Inform Assoc; 2001; 8(3):254-66. PubMed ID: 11320070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug events among adult inpatients: a meta-analysis of observational studies.
    Martins AC; Giordani F; Rozenfeld S
    J Clin Pharm Ther; 2014 Dec; 39(6):609-20. PubMed ID: 25219403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for detecting adverse drug events among older persons in the ambulatory setting.
    Field TS; Gurwitz JH; Harrold LR; Rothschild JM; Debellis K; Seger AC; Fish LS; Garber L; Kelleher M; Bates DW
    J Am Med Inform Assoc; 2004; 11(6):492-8. PubMed ID: 15299000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ICD-10-CM T codes in hospital claims data to identify adverse drug events in Taiwan.
    Cheng YF; Cheng CY; Wang SH; Lin YT; Tsai TC
    J Clin Pharm Ther; 2021 Apr; 46(2):476-483. PubMed ID: 33210301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug event detection in a community hospital utilising computerised medication and laboratory data.
    Seger AC; Jha AK; Bates DW
    Drug Saf; 2007; 30(9):817-24. PubMed ID: 17722972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study.
    Lau EY; Cragg A; Small SS; Butcher K; Hohl CM
    JMIR Hum Factors; 2024 Jan; 11():e52495. PubMed ID: 38236629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of nursing home physicians to determine laboratory monitoring adverse drug event alert preferences.
    Boyce RD; Perera S; Nace DA; Culley CM; Handler SM
    Appl Clin Inform; 2014; 5(4):895-906. PubMed ID: 25589905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
    Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
    PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study.
    Zimlichman E; Gueta I; Daliyot D; Ziv A; Oberman B; Hochman O; Tamir O; Tal O; Loebstein R
    Isr Med Assoc J; 2018 Nov; 20(11):665-669. PubMed ID: 30430793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of medication-related triggers to determine adverse drug events.
    Augustino M; Rowcliffe M; Feemster A; Smith J; Duncan R
    Eur J Hosp Pharm; 2023 Mar; 30(2):92-95. PubMed ID: 35177534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescribing discrepancies likely to cause adverse drug events after patient transfer.
    Boockvar KS; Liu S; Goldstein N; Nebeker J; Siu A; Fried T
    Qual Saf Health Care; 2009 Feb; 18(1):32-6. PubMed ID: 19204129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.
    Jha AK; Kuperman GJ; Teich JM; Leape L; Shea B; Rittenberg E; Burdick E; Seger DL; Vander Vliet M; Bates DW
    J Am Med Inform Assoc; 1998; 5(3):305-14. PubMed ID: 9609500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU).
    Kane-Gill SL; Bellamy CJ; Verrico MM; Handler SM; Weber RJ
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1185-91. PubMed ID: 19728294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.